New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2014
07:30 EDTSYK, VJET, EADSY, GE, SSYS, JNJ, XONE, DDDMajor industrial groups in talks with 3D printing companies, says Jefferies
Jefferies says its channel checks indicate 6-12 major industrial groups are in serious discussions with metal 3D printing companies about major orders for printers that will be integrated into existing production lines. The firm thinks GE (GE), Stryker (SYK), Johnson & Johnson (JNJ), EADS, Airbus (EADSY), BMW, and others are likely to place major orders this year. Makers of 3D printers include 3D Systems (DDD), Stratasys (SSYS), Voxeljet (VJET) and ExOne (XONE).
News For DDD;SSYS;VJET;XONE;GE;SYK;JNJ;EADSY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
November 14, 2014
15:12 EDTVJETVoxeljet management to meet with Piper Jaffray
Subscribe for More Information
14:53 EDTJNJCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
10:10 EDTDDDOptions with decreasing implied volatility
Subscribe for More Information
09:38 EDTGEActive equity options trading
Subscribe for More Information
08:33 EDTXONEExOne momentum may improve in 2015, says Oppenheimer
After ExOne reported weaker than expected Q3 results, Oppenheimer says the company was confident that its performance will improve in Q4. The firm thinks that ExOne's 2015 guidance looks conservative, while the company's momentum may improve significantly in 6-12 months. It keeps an Outperform rating on the shares.
08:20 EDTXONEExOne price target lowered to $37 from $45 at FBR Capital
FBR Capital lowered its price target for ExOne shares to $37 saying deferrals impacted the company's Q3 results. The firm keeps an Outperform rating on the stock.
08:04 EDTGEGE Capital provides $37.5M credit facility to Specialty's Cafe & Bakery
Subscribe for More Information
08:00 EDTGEHalliburton, Baker deal would face 'intense' DOJ scrutiny, says Jefferies
Subscribe for More Information
November 13, 2014
18:40 EDTVJETOn The Fly: After Hours Movers
UP AFTER EARNINGS: TubeMogul (TUBE), up 12.4%... Weibo (WB), up 3.2%... Nordstrom (JWN), up 3.1%. ALSO HIGHER: Geron (GERN), up 30.7% after announcing a global strategic collaboration with Janssen Biotech... Baker Hughes (BHI), up 16.2% following reports that the company is in talks to be acquired by Halliburton (HAL)... Halliburton is up 1.4%... Pandora (P), up 4% after announcing a conference call to discuss Web IV proceeding... AmerisourceBergen (ABC), up 1.1% after being awarded a $4.06B government contract. DOWN AFTER EARNINGS: Retrophin (RTRX), down 6.6%... Phoenix New Media (FENG), down 8.4%... Voxeljet AG (VJET), down 8.6%... Intrexon (XON), down 1.1%... Youku Tudou (YOKU), down 5.7%... Applied Materials (AMAT), down 2.5%. ALSO LOWER: Puma Biotechnology (PBYI), down 6.9% following PB272 Phase II Trial results... EnLink Midstream (ENLK), down 4.8% after filing to sell 10.5M common units representing limited partners.
17:26 EDTVJETVoxeljet lowers 2014 revenue view to EUR15M-16M from above EUR18M
Subscribe for More Information
17:23 EDTVJETVoxeljet reports Q3 EPS EUR(41c) vs. EUR11c a year ago
Subscribe for More Information
16:28 EDTJNJGeron announces global strategic collaboration with Janssen Biotech
Geron (GERN) announced that the company has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, a Johnson & Johnson (JNJ) company, to develop and commercialize, imetelstat, Geron's telomerase inhibitor product candidate, for oncology, including hematologic malignancies, and other human therapeutics uses. Imetelstat is a modified oligonucleotide that is currently in early phase clinical development for myelofibrosis, or MF, and may have activity in other hematologic myeloid malignancies such as myelodysplastic syndrome, or MDS, and acute myelogenous leukemia, or AML. Under the terms of the agreement, Geron will receive an initial payment of $35M due after the applicable waiting periods under the Hart-Scott Rodino Act and is eligible to receive additional payments up to a potential total of $900M for the achievement of development, regulatory and commercial milestones, as well as royalties on worldwide net sales. Certain regulatory, development, manufacturing and promotional activities will be managed through a joint governance structure, with Janssen responsible for operational implementation of these activities. All sales will be booked by Janssen.
13:17 EDTSSYSMakerBot acquires Layer by Layer, terms not disclosed
MakerBot, a subsidiary of Stratasys, announced the acquisition of the start-up software company Layer By Layer. The goal of the acquisition of Layer By Layer is to help accelerate MakerBotís position in the entertainment and 3D printing management spaces, as part of its effort to build a more robust 3D ecosystem.
11:54 EDTJNJJanssen announces FDA approved sNDA for INVEGA SUSTENNA
Subscribe for More Information
11:12 EDTGEHungary to buy Budapest from GE Capital, Reuters reports
Subscribe for More Information
10:44 EDTJNJMallinckrodt news on generic Concerta positive for Actavis, says BMO Capital
Subscribe for More Information
10:04 EDTGEGE opens $500M Brazil Technology Center
Subscribe for More Information
08:52 EDTEADSYInfosys among suitors for Airbus' CIMPA unit, Economic Times says
Infosys (INFY) is among the suitors looking to acquire CIMPA, the engineering services unit of Airbus (EADSY), said Economic Times, citing people familiar with the matter, who added that Infosys could also get a revenue assurance from Airbus as part of a deal. Reference Link
07:26 EDTGEGE sees great infrastructure demand in developing markets, Reuters says
Subscribe for More Information
06:31 EDTEADSYAirbus A350-900 receives FAA Type Certification
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use